The standard angiographic projections, each rendered from the gated CT in this atlas (ImageCAS case 11, a right-dominant heart). Every image is a projection of this patient's segmented coronary lumen at that C-arm angle, so overlap and foreshortening are real for this heart. Optimal angles differ from patient to patient.
Which projection is this? Find the spine (LAO or RAO) and the diaphragm (higher in cranial views), then read the shape of the vessels.
Rendering views from the CT…
Angiograms here are projections of the CT-segmented lumen (ImageCAS-X labels), not recorded cine. They show anatomy and overlap only: no flow, catheter or diaphragm shadow. The spine, ribs, sternum and diaphragm come from the same CT; the diaphragm is drawn as the soft tissue beneath the lung bases, so there is no edge under the heart itself. The CT was reconstructed on a cardiac field of view of about 17 cm, so only structures close to the heart appear. Optimal angles, and how far the diaphragm rises, vary with each patient and with breath-hold depth. "Length shown" is approximate: it uses each segment's main axis and is given only for fairly straight segments.
What the trials and expert reviews say about access, catheter choice and catheter-related complications, followed by cases to test yourself. Each statement carries its evidence type.
Radial access is a Class 1, Level A recommendation for PCI in both ACS and stable ischemic heart disease, to reduce bleeding and vascular complications, and in ACS, death.
22 randomised trials and 10,287 patients. Left radial access reduced fluoroscopy time and contrast use, with strong between-trial heterogeneity and no significant difference in failure rate.
A universal catheter saves an exchange and some contrast in routine diagnostic work. Keep Judkins shapes ready, because about one in five cases changes catheter either way.
Read the diagnostic angiogram for four things before choosing: aortic root size, left main length, take-off of the target vessel, and lesion location. Then match the guide's lumen and support to the devices you may need. Expert review Pavei et al., EuroIntervention 2010 [9]
| Situation | Suggested shapes | Why |
|---|---|---|
| Left coronary, femoral, normal aorta and left main | EBU 4 or JL 4 | Downsize to 3.5 or upsize to 4.5 as the root requires. |
| Left coronary, large aorta | EBU 4–4.5 or JL 5; AL 2–3 | The larger curve reaches the ostium; Amplatz shapes add support. |
| Complex LCx lesion | AL | Deep, coaxial engagement and strong backup, but aggressive: handle very gently. |
| RCA, superior take-off | AL, AR or hockey stick | The hooked tip aligns with an upward-pointing ostium. |
| RCA, inferior take-off | JR, JR short tip, MP, bypass right | The tip points down along the vessel's course. |
| Internal mammary graft | IMA catheter | Sits coaxially in the IMA ostium with support from the subclavian. |
| SVG to OM, hard to cross with a filter | AL 1–2, preferably 7 Fr | Better backup force. |
| SVG to RCA | MP; hockey stick as an alternative | Matches the inferior course of right-sided grafts. |
| Left coronary from the right radial | EBU 3.5 or JL 3.5 | About 0.5 cm smaller than the femoral choice for the same root. |
| RCA from the right radial | JR (often JR 5) | About 1 cm larger than the femoral choice helps. |
| From the left radial | Conventional curves | The course resembles the femoral approach. |
| Inadequate support (LCx or RCA) | AL; AL 0.75 for the RCA | AL 0.75 is less aggressive than AL 1 with similar support. |
| Rotational atherectomy | 6 Fr: 1.5 mm burr · 7 Fr: 1.75 mm · 8 Fr: ≥2 mm | Guide lumen limits burr size. |
Keep the catheter coaxial, watch the pressure trace before every injection, and stop injecting through the catheter once a dissection is seen, because more contrast can extend it. IVUS helps locate the entry point and guide ostial stent coverage.
Choose an answer to see the explanation and its source.
Teaching material summarising published evidence. It does not replace institutional protocols, current guidelines or supervised training. Practice statements without trial data are labelled as expert review or practice.
Scroll through simulated pullbacks, switch between IVUS and OCT on the same vessel, measure what you see, and test yourself against the criteria the trials used. The criteria, cut-offs and trial results below are taken from the cited papers.
◇ Simulated images: a teaching model of backscatter and attenuation, not patient recordingsIVUS uses ultrasound, so it sees through blood and deep into the wall but blurs detail. OCT uses near-infrared light, so it needs a contrast flush to clear blood and penetrates only a millimetre or two, but resolves structures about ten times finer. Most of the differences below follow from that.
| Feature | IVUS | OCT |
|---|---|---|
| Resolution and depth (approximate) | Axial resolution roughly 100–200 µm; sees the whole vessel wall and beyond | Axial resolution roughly 10–20 µm; penetration about 1–2 mm, so the vessel border can be lost behind lipid |
| Blood in the lumen | Sparkling speckle that moves frame to frame | Must be flushed with contrast; residual blood blurs and shadows the image |
| Normal wall | Bright intima, dark (echolucent) media, bright adventitia | Three layers: signal-rich intima, signal-poor media, heterogeneous adventitia |
| Fibrous plaque | Homogeneous, intermediate brightness | Signal-rich and homogeneous, low attenuation |
| Lipid / necrotic core | Attenuated plaque: deep signal loss without bright calcium | Signal-poor region with diffuse borders and high attenuation under a fibrous cap; cap thickness can be measured |
| Calcium | Very bright leading edge with an acoustic shadow behind it; thickness cannot be measured | Signal-poor with sharp borders; light passes through, so arc and thickness can be measured |
| Thin-cap fibroatheroma | Not resolvable (cap below IVUS resolution) | Lipid with a fibrous cap < 65 µm |
| Thrombus | Low-echo, layered or lobulated intraluminal mass | Red thrombus: high backscatter with strong shadowing. White thrombus: high backscatter, low attenuation |
| Stent struts | Bright arcs with shadows | Bright lines with sharp, complete shadows; apposition can be measured strut by strut |
| Guidewire | Bright dot with a shadow, in every frame | Bright dot with a wedge-shaped shadow |
| Trial | Population | Comparison | Primary result |
|---|---|---|---|
| IVUS-XPL (JAMA 2015) | 1,400 patients, stents ≥ 28 mm | IVUS vs angiography | MACE at 1 year 2.9% vs 5.8% (HR 0.48), driven by less ischaemia-driven TLR |
| ULTIMATE (JACC 2018) | 1,448 all-comers | IVUS vs angiography | TVF at 1 year 2.9% vs 5.4% (HR 0.53); 1.6% when all IVUS optimal criteria were met vs 4.4% when not |
| RENOVATE-COMPLEX-PCI (NEJM 2023) | 1,639 complex lesions | IVUS or OCT vs angiography (2:1) | Cardiac death, TV-MI or TVR 7.7% vs 12.3% at median 2.1 years (HR 0.64) |
| OCTOBER (NEJM 2023) | 1,201 complex bifurcations | OCT vs angiography | MACE at 2 years 10.1% vs 14.1% (HR 0.70) |
| ILUMIEN IV (NEJM 2023) | 2,487 diabetic or complex-lesion patients | OCT vs angiography | Larger MSA (5.72 vs 5.36 mm²); TVF at 2 years 7.4% vs 8.2% (HR 0.90, not significant); stent thrombosis 0.5% vs 1.4% |
| OCTIVUS (Circulation 2023) | 2,008 patients | OCT vs IVUS | OCT non-inferior: 2.5% vs 3.1% at 1 year; fewer major procedural complications with OCT (2.2% vs 3.7%) |
| ILUMIEN III (Lancet 2016) | 450 patients | OCT vs IVUS vs angiography | Median MSA 5.79, 5.89 and 5.49 mm². OCT non-inferior to IVUS, not superior to angiography |
| Network meta-analysis (Lancet 2024) | 22 RCTs, 15,964 patients | Imaging (IVUS or OCT) vs angiography | Target lesion failure RR 0.71; cardiac death RR 0.55; stent thrombosis RR 0.52; all-cause death RR 0.75. OCT and IVUS similar |
Guidelines: the 2024 ESC chronic coronary syndrome guideline recommends IVUS or OCT guidance for PCI of anatomically complex lesions, in particular left main, true bifurcations and long lesions (Class I) [ESC 2024]. The 2021 ACC/AHA/SCAI revascularisation guideline gives IVUS a Class 2a recommendation for stent guidance, especially in left main or complex stenting, and lists OCT as a reasonable alternative except in ostial left main disease [ACC/AHA/SCAI 2021].
Trial results are quoted from the published abstracts. Criteria quoted from the EAPCI consensus, ULTIMATE and the IVUS calcium score were checked against open-access papers citing them. The simulator is a schematic tissue model: its images and measurements illustrate the criteria, they are not patient data.
Pressure wires, cath-lab waveforms and circulatory support, built as working models: move the inputs and watch the tracings and the numbers change. Thresholds and trial results come from the cited papers; the tracings are generated by a teaching model, not recorded from patients.
| Study | Question | Result |
|---|---|---|
| Pijls 1996 (NEJM) | Does FFR identify ischaemia? | FFR < 0.75: 88% sensitivity, 100% specificity against non-invasive tests |
| DEFER, 15 years (EHJ 2015) | Defer PCI if FFR ≥ 0.75? | Death no different (33.0% deferred vs 31.1% stented); MI lower when deferred (2.2% vs 10.0%) |
| FAME (NEJM 2009) | FFR-guided (≤ 0.80) vs angiography-guided multivessel PCI | Death, MI or repeat revascularisation at 1 year 13.2% vs 18.3%, with fewer stents (1.9 vs 2.7) |
| FAME 2 (NEJM 2012) | PCI + medical therapy vs medical therapy when FFR ≤ 0.80 | Primary end point 4.3% vs 12.7% (HR 0.32), driven by urgent revascularisation |
| DEFINE-FLAIR (NEJM 2017) | iFR vs FFR to guide revascularisation | iFR non-inferior (6.8% vs 7.0%); procedural symptoms 3.1% vs 30.8% |
| iFR-SWEDEHEART (NEJM 2017) | iFR vs FFR, stable angina and ACS | iFR non-inferior (6.7% vs 6.1%) |
| FAME 3 (NEJM 2022) | FFR-guided PCI vs CABG in three-vessel disease | PCI not non-inferior at 1 year (10.6% vs 6.9%; HR 1.5) |
| FLOWER-MI (NEJM 2021) | FFR vs angiography to guide non-culprit PCI in STEMI | No significant benefit of FFR (5.5% vs 4.2%; HR 1.32) |
| FIRE (NEJM 2023) | Physiology-guided complete vs culprit-only PCI, MI age ≥ 75 | Complete revascularisation better (15.7% vs 21.0%; HR 0.73) |
| FAVOR III China (Lancet 2021) | Angiography-derived QFR vs angiography alone | QFR guidance better at 1 year (5.8% vs 8.8%; HR 0.65) |
| FAVOR III Europe (Lancet 2024) | QFR vs FFR | QFR did not meet non-inferiority (6.7% vs 4.2%; HR 1.63) |
| VALIDATE-RFR (EuroIntervention 2018) | Resting full-cycle ratio vs iFR | Diagnostic accuracy 97.4% against iFR |
| CorMicA (JACC 2018) | Stratified therapy after coronary function testing in angina without obstructive CAD | Seattle Angina summary score improved by 11.7 units at 6 months; MACE no different |
| Talreja 2008 (JACC) | Constriction vs restrictive myocardial disease at catheterisation | Systolic area index: 97% sensitivity, 100% predictive accuracy; conventional criteria < 75% accurate |
Cut-offs used in the lab: FFR ≤ 0.80 (FAME, FAME 2) and iFR ≤ 0.89 for haemodynamic significance; CFR < 2.0 and IMR ≥ 25 for coronary microvascular dysfunction, with IMR = Pd × mean transit time at hyperaemia [Ford 2018 and related]. For constriction: end-diastolic pressure equalisation < 5 mmHg and systolic area index > 1.1.
Trial numbers are quoted from PubMed abstracts. Cut-offs not stated in those abstracts (iFR 0.89, CFR 2.0, IMR 25, SAI 1.1, Gorlin constants) were checked in open-access papers that use them. The waveforms are generated by a teaching model and illustrate the physiology; they are not patient data.
Complications and bailout, bifurcation technique, calcium modification and chronic total occlusions. The scenarios are decision trainers, and the drawings are schematic; device sizes in the bifurcation module come from this atlas's own CT, and the criteria come from the cited consensus papers and trials.
Tick each segment with ≥ 50% stenosis.
| Study | Question | Result |
|---|
Results are quoted from PubMed abstracts; consensus statements (CVIT 2025 bailout algorithms, SCAI 2024 calcified lesions) and classification definitions were checked in open-access full texts. The scenarios and drawings are schematic teaching aids.
Place a stenosis in this patient's real mid LAD, just after the first diagonal, and watch the same lesion on CT, on two angiographic projections, on IVUS and OCT, and on the pressure wire. Change its severity, length or plaque type and every panel updates together.
◇ Simulated lesion inserted into a normal CT (ImageCAS case 11). The CT background and anatomy are real; the plaque, the narrowed angiographic lumen, the IVUS/OCT frames and the FFR come from teaching models.Waiting for the CT volume…
Rendered by the atlas from the CT lumen with the lesion inserted.